Bottaro, Elisabetta
Paterson, Jemma A. J.
Quercia, Luciano
Zhang, Xunli
Hill, Martyn
Patel, Venisha A.
Jones, Stephen A.
Lewis, Andrew L.
Millar, Timothy M.
Carugo, Dario
Article History
Received: 26 June 2018
Accepted: 21 June 2019
First Online: 8 July 2019
Competing Interests
: E.B. is in receipt of a Doctoral Training Partnership funded from EPSRC and Biocompatibles UK Ltd., a BTG International group company. J.P., L.Q., X.Z., M.H., T.M.M. and D.C. declare no potential conflict of interest. A.L.L., S.A.J. and V.A.P. are paid employees of Biocompatibles UK Ltd. The commercially-available sclerosant used in this study (Varithena) is manufactured by Biocompatibles UK Ltd. on behalf of Provensis Ltd.